USPTO Updates Indefiniteness Standard in AIA Post-Grant Proceedings to Match Those of the District Court Under Nautilus READ MORE
The Federal Circuit “OK”s a Questionable Path to Petitioning for Cancellation of a Trademark Registration READ MORE
A Look Back at Risk Evaluation and Mitigation Strategies at the Food and Drug Administration in 2020: Year in Review READ MORE
Venue in Hatch-Waxman Litigation: What Courts Decided and What Litigants are Still Fighting Over READ MORE
Vectura Ltd. v. GlaxoSmithKline LLC: Federal Circuit Panel Affirms Vectura’s $90 Million Damages Award READ MORE
